Evidence map›Paper›PMID 36475023›Full record

ArticleRegenerative therapy2022

Proteomics reveals the potential mechanism of Tanshinone IIA in promoting the

Pei Yuan, Hong-Yan Qin, Jia-Yun Wei, Geshuyi Chen, Xun Li

Open access · goldAbstract read
In one paragraph

Article in Regenerative therapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Pei YuanThe First Clinical Medical College, Lanzhou University, Lanzhou, China.
Hong-Yan QinDepartment of Pharmacy, The First Hospital of Lanzhou University, Lanzhou, China.
Jia-Yun WeiThe First Clinical Medical College, Lanzhou University, Lanzhou, China.
Geshuyi ChenThe First Clinical Medical College, Lanzhou University, Lanzhou, China.
Xun LiThe First Clinical Medical College, Lanzhou University, Lanzhou, China.
First Hospital of Lanzhou University · CNSecond Military Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Bone marrow mesenchymal stem cells (BMSCs) are a promising cell type for tissue engineering, however, the application of BMSCs is largely hampered by the limited number harvested from bone marrow cells. The methods or strategies that focused on promoting the capacity of BMSCs expansion Methods: In this present study, the effect of Tan IIA on the expansion capacity of BMSCs from human was investigated, and quantitative proteome analysis was applied furtherly to identify the differentially expressed proteins (DEPs) and the molecular signaling pathways in Tan IIA-treated hBMSCs. Finally, molecular biology skills were employed to verify the proposed mechanism of Tan IIA in promoting hBMSCs expansion. Results: The results showed that a total of 84 DEPs were identified, of which 51 proteins were upregulated and 33 proteins were downregulated. Besides, Tan IIA could promote hBMSCs proliferation by regulating the progression of S phase via increasing the release of fibroblast growth factor 2 (FGF2), FGF-mediated PI3K/AKT signaling pathways may play an important role in Tan IIA's effect on hBMSCs expansion. Conclusions: This study employed molecular biology skills combined with quantitative proteome analysis, to some extent, clarified the mechanism of Tan IIA's effect on promoting hBMSCs proliferation, and will give a hint that Tan IIA may have the potential to be used for BMSCs applications in cell therapies in the future.

Indexed as

AutocrineBMSCs, bone marrow mesenchymal stem cellsBone marrow mesenchymal stem cellsCDK, cyclin-dependent kinaseCOG, Clusters of Orthologous Groups of proteinsDEPs, differentially expressed proteinsDMSO, dimethyl sulfoxideEdU, 5' Ethynyl 2' deoxyuridineExpansionFC, Fold ChangeFDR, false discovery rateFGF1/2, fibroblast growth factor 1/2FGFR, FGF receptorFibroblast growth factor 2GO, Gene OntologyHPLC, high performance liquid chromatographyKEGG, Encyclopedia of Genes and GenomesLC-MS, liquid chromatography-mass spectrometryMTT, Three-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromidePCNA, proliferating cell nuclear antigenPPI, protein–protein interactionsProteomicsTan IIA, Tanshinone IIATanshinone IIATEAB, triethylammonium bicarbonateTMT, tendam mass tags

Identifiers

PMID36475023
PMCPMC9700269
OpenAlexW4309896548

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.